| US 7,569,540 B2 | ||
| Method for enhanced parenteral nutrition | ||
| Michael A. Nauck, Bochum (Germany); and Fred A. Wagner, Walton, Nebr. (US) | ||
| Assigned to Amylin Pharmaceuticals, Inc., San Diego, Calif. (US) | ||
| Filed on May 10, 2004, as Appl. No. 10/842,933. | ||
| Application 10/842933 is a continuation of application No. 09/011940, granted, now 6,852,690, previously published as PCT/US96/13615, filed on Aug. 22, 1996. | ||
| Claims priority of application No. 195 30 865 (DE), filed on Aug. 22, 1995. | ||
| Prior Publication US 2004/0209814 A1, Oct. 21, 2004 | ||
| This patent is subject to a terminal disclaimer. | ||
| Int. Cl. A61K 28/38 (2006.01); C12P 21/02 (2006.01) | ||
| U.S. Cl. 514—3 [514/14; 514/13; 514/12; 514/23; 530/308; 530/324] | 15 Claims |
| 1. A method for non-alimentary nutrition comprising administering by a parenteral route to a patient in need of parenteral
nutrition;
a nutritively effective amount of nutrient composition comprising from about 2% to about 50% glucose or the equivalent thereof;
and
an insulinotropic peptide or peptides selected from the groups consisting of a GLP-1, an exendin, the deletion sequences thereof,
the natural and non-natural amino acid substitutes thereof, the C-terminus carboxyamides thereof, the C-terminus ketones thereof,
the N-terminus modifications thereof, and any mixture thereof.
|